A non-randomised, single-centre comparison of induction chemotherapy followed by radiochemotherapy versus concomitant chemotherapy with hyperfractionated radiotherapy in inoperable head and neck carcinomas

Table 4 Comparison of treatment results between the two groups

	SEQ	CON	p
Overall survival (5 ys.)	14.7 %	23.7 %	0.11
Median overall survival	14.6 months	20.1 months
Disease-free survival (5 ys.)	19.8 %	31.4 %	0.08
Progression free survival (5 ys.) years)	17.6 %	41.0%	0.03
Median time to (local) progression	10.7 months	15.0 months

¹⁾ WHO ²⁾ compared with response in the SEQ-group after chemotherapy and radiotherapy

ISSN: 1471-2407